Comparison of MAG and Fish Oil Efficacy

Exclusion Criteria

• •Binge eating disorder
• •Any other weight loss treatment(s) within the last 3 months
• •Vegetarians
• •History of metabolic, cardiovascular, hepatic or renal diseases
• •Obstructed bile duct
• •Diseases that could interfere with intestinal absorption History of abdominal / gastric surgery (except appendicectomy)
• •Use of drugs or illicit substances
• •Consumption of alcohol \> 50 gr/week
• •Any other clinically significant abnormalities on screening laboratory evaluation (creatinine, Na, K, urique acide, ASAT, ALAT, Ph. Alc., yGT, Glycemia, total cholesterol, HDL, LDL, triglycerides) concentrations \> 2.5 fold normal range
• •Pregnant or lactating mothers
• •Allergy to fish oil or other components (for e.g., gelatin or excepients of the capsule)
• •Use of any other supplements containing fish oil for the duration of the trial or 3 month before inclusion in trial.
• •Smokers
• •Having donated blood or had a transfusion of blood/blood products during the trial and 3 months prior to screening or expected to do so during the study
• •Bleeding disorders
• •Subject who cannot be expected to comply with the study procedures.
• •Currently participating or having participated in another clinical trial during last 8 weeks prior to the beginning of this study.